Why Biocryst Has Wings

摘要

SHARES OF BIOCRYST PHARMACEUTICALS (BCRX) are on fire,soaring from 4.39 a share in early April to 15 on Oct.19.The reason:bird flu.With the increasing global concern over avian influenza,"Biocryst is attracting investor attention because of its antiviral drug,Peramivir,which some scientists see as a promising treatment for avian flu," says John McCamant,editor of the Medical Technology Stock Letter.